PERK activation also up-regulates ER-resident endoplasmic oxidoreductin-1 alpha (Ero1α) to promote protein folding in the ER, resulting in increased oxidative protein folding capacity, favoring cancer growth (3). The gene discussed is EIF2AK3; the disease is cancer.